Analyst Upgrades: Heron Therapeutics Inc, Finish Line Inc, and Total SA

Analysts upwardly revised their ratings on Heron Therapeutics Inc (HRTX), Finish Line Inc (FINL), and Total SA (ADR) (TOT)

Sep 23, 2015 at 9:09 AM
facebook X logo linkedin

Analysts are weighing in today on drugmaker Heron Therapeutics Inc (NASDAQ:HRTX), retailer Finish Line Inc (NASDAQ:FINL), and energy operator Total SA (ADR) (NYSE:TOT). Here's a quick roundup of today's bullish brokerage notes on HRTX, FINL, and TOT.

  • HRTX is rocketing higher in pre-market trading, after the company's pain drug met a mid-stage study goal -- prompting no fewer than four price-target hikes. The most ambitious came from Jefferies, which lifted its target to $58 -- representing a 72.8% premium to HRTX's close of $33.56 yesterday. The shares are pointed 23.7% north this morning -- more of the same for Heron Therapeutics Inc, which has almost quadrupled in value year-over-year. Short sellers could fuel even more upward momentum, as they begin to throw in the towel on their losing bets. A lofty 12.6% of HRTX's float is sold short, which would take one week to buy back, at the stock's typical daily volume.

  • Ahead of Friday morning's earnings report, FINL saw its rating bumped to "outperform" from "market perform," and its price target raised to $30 from $28, at FBR. FINL has advanced just 1.4% in 2015, as of Tuesday's close at $24.66, but is pointed 9% higher in pre-market trading. Option traders have been ramping up their bearish bets in light of Finish Line Inc's recent pullback, which kicked off with the broader equities market on Aug. 21. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), FINL has racked up a 50-day put/call volume ratio of 1.81 -- in the 78th percentile of its annual range.

  • Macquarie started coverage on TOT with an "outperform" rating and 48 euro price target, and also named the stock a "top pick" -- despite predicting that oil companies' "current very positive strength" in downstream earnings will fade by year-end. Separately, Total SA (ADR) is making headlines after cutting capex and output targets, though the firm reassured investors its dividend was safe. The brokerage crowd is already overwhelmingly optimistic toward the shares. Eight of 11 analysts tracking TOT have doled out a "buy" or better rating -- with not a single "sell" in sight -- while its consensus 12-month price target of $55.03 stands at a 25.7% premium to yesterday's close at $43.79. Ahead of the bell, the stock is up nearly 2%.

Get the skinny on all the biggest stories of the morning… Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI